RecruitingPhase 3NCT07662109
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Annapolis, MD · Lutherville-Timonium, MD · Oxon Hill, MD · +37 more sites